Sen. Chuck Grassley, R-Iowa, chair of the Senate Finance Committee, prepares for the Feb. 26, 2019 hearing with CEOs from several U.S. drug makers. Pablo Martinez Monsivais/AP Photo Neeraj Sood, University of Southern California On the heels of congressional testimony by the CEOs of major drug makers, there are some important things to keep in mind.